Apart from developing new manufacturing processes for the latest APIs, the company also undertakes contract manufacturing or custom synthesis using either its partner's or its own know-how.
Based on this in-house technology and complete project portfolio of original non-infringing chemical synthesis pathways for the scale-up, manufacture and production of the newest APIs currently available.
CF Pharma is licensed by the National Institute of Pharmacy (Hungary) for warehouse quarantine, quality assurance and release of finished products manufactured either within the EU or in non-EU countries
for distribution throughout the enlarged EU.
In addition, we can also ensure the manufacture and production of finished products starting from APIs or endstage intermediates for registration in Hungary followed by registration throughout the EU on the basis
of Mutual Recognition Procedure (MRP).
In addition, we can also ensure the manufacture and production of finished products starting from APIs or endstage intermediates for registration in Hungary followed by registration throughout the EU on the basis
of Mutual Recognition Procedure (MRP).
|
